First Patient Begins Newly Approved Sickle Cell Gene Therapy

Kendric Cromer, a 12-year-old from Washington, has become the first person to receive a newly approved gene therapy for sickle cell disease. This marks a significant development for the 20,000 eligible patients in the U.S., promising a potential cure and a hope for normalcy. The treatment represents a major step for those affected by the disease, often disrupting ordinary activities with severe pain. Kendric now sees a chance for a life free from the limitations imposed by sickle cell disease.